Home/Filings/4/0001209191-22-007634
4//SEC Filing

Dasu Badri N 4

Accession 0001209191-22-007634

CIK 0001427925other

Filed

Feb 6, 7:00 PM ET

Accepted

Feb 7, 8:19 PM ET

Size

5.2 KB

Accession

0001209191-22-007634

Insider Transaction Report

Form 4
Period: 2022-02-06
Dasu Badri N
Chief Engineering Officer
Transactions
  • Tax Payment

    Common Stock

    2022-02-06$0.43/sh6,830$2,945204,322 total
Footnotes (3)
  • [F1]Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs.
  • [F2]Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
  • [F3]Balance includes non-reportable acquisition of 6,395 shares of Common Stock through the Company's Employee Stock Purchase Plan.

Issuer

ACELRX PHARMACEUTICALS INC

CIK 0001427925

Entity typeother

Related Parties

1
  • filerCIK 0001310803

Filing Metadata

Form type
4
Filed
Feb 6, 7:00 PM ET
Accepted
Feb 7, 8:19 PM ET
Size
5.2 KB